Skip to main content
. 2020 Oct 19;11(12):3501–3509. doi: 10.1111/1759-7714.13689

Figure 2.

Figure 2

The swimmer plot of progression‐free survival (PFS) from the initiation of immunotherapy according to (a) the entire cohort; (Inline graphic) Combination therapy and (Inline graphic) monotherapy and (b) different combination regimens (Inline graphic) ICIs plus chemotherapy and antiangiogenic drugs, (Inline graphic) ICIs plus chemotherapy, and (Inline graphic) ICIs plus antiangiogenic drugs.